HERZLIA, Israel--(BUSINESS WIRE)--Endospan, a pioneer in off-the-shelf endovascular repair of aortic arch disease was recently granted Breakthrough Device Designation from the U.S. Food and Drug ...
PITTSBURGH—University of Pittsburgh-led researchers could provide new insight into how two common congenital circulatory problems—aortic arch deformity and arteriovenous malformations (AVMs)—develop ...
Endospan, a privately held company pioneering solutions for the endovascular repair of aortic arch disease, today announced the one-year results of their TRIOMPHE Investigational Device Exemption (IDE ...
Future generations of aortic specialists will not only need to master endovascular techniques but also collectively work to preserve the open aortic skill set.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results